HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Francone, O. L. Articles by Fielding, C. J. Search for Related Content PubMed PubMed Citation Articles by Francone, O. L. Articles by Fielding, C. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 1609-1615, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Effects of carboxy-terminal truncation on human lecithin:cholesterol acyltransferase activity

OL Francone, L Evangelista and CJ Fielding
Cardiovascular Research Institute, University of California Medical Center, San Francisco 94143, USA.

Mutagenesis was carried out in human lecithin:cholesterol acyltransferase (LCAT) to generate mutants with stop codons at positions corresponding to amino acids 315, 341, 359, 375, 388, 394, and 398 of the 416-amino acid sequence of the mature enzyme protein. Deletion of the 18 terminal amino acids of the protein was without effect on LCAT phospholipase or acyltransferase activity, or the stability of the protein to denaturation at 37 degrees C. Further deletion led to loss of most of the activity, associated with a 10-fold increase in the rate of denaturation at 37 degrees C. These data indicate that the proline-rich C-terminus of LCAT is not required for effective enzyme activity. The loss of activity that accompanied deletion of residues 394-398 suggests a structural role for these residues, part of a series of predicted beta-sheet sequences in the C- terminal third of the LCAT primary sequence.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Peelman, B. Vanloo, J.-L. Verschelde, C. Labeur, H. Caster, J. Taveirne, A. Verhee, N. Duverger, J. Vandekerckhove, J. Tavernier, et al. Effect of mutations of N- and C-terminal charged residues on the activity of LCAT J. Lipid Res., April 1, 2001; 42(4): 471 - 479. [Abstract] [Full Text]

				J. W. Chisholm, A. K. Gebre, and J. S. Parks Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferase J. Lipid Res., August 1, 1999; 40(8): 1512 - 1519. [Abstract] [Full Text]

				F. Peelman, J-L. Verschelde, B. Vanloo, C. Ampe, C. Labeur, J. Tavernier, J. Vandekerckhove, and M. Rosseneu Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity J. Lipid Res., January 1, 1999; 40(1): 59 - 69. [Abstract] [Full Text]

				J. Kosman and A. Jonas Deletion of Specific Glycan Chains Affects Differentially the Stability, Local Structures, and Activity of Lecithin-cholesterol Acyltransferase J. Biol. Chem., September 28, 2001; 276(40): 37230 - 37236. [Abstract] [Full Text] [PDF]